# Impact of Early Lung Physiology, Viral Infections and the Microbiota on the Development and Progression of Lung Disease in Children With Cystic Fibrosis

> **NCT04026360** · — · RECRUITING · sponsor: **Insel Gruppe AG, University Hospital Bern** · enrollment: 500 (estimated)

## Conditions studied

- Confirmed Diagnosis of Cystic Fibrosis

## Interventions

- **OTHER:** no intervention

## Key facts

- **NCT ID:** NCT04026360
- **Lead sponsor:** Insel Gruppe AG, University Hospital Bern
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2011-07-01
- **Primary completion:** 2050-08-31
- **Final completion:** 2050-12-31
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2020-11-04

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04026360

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04026360, "Impact of Early Lung Physiology, Viral Infections and the Microbiota on the Development and Progression of Lung Disease in Children With Cystic Fibrosis". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT04026360. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*